WATSON Pharmaceuticals today
announced a global name change,
with the business to take on the
branding of Actavis which it has
now formally acquired, creating the
third largest global generics
company in the world.
The company has also confirmed
a restructured management team,
with the Australian operation to be
led by former Apotex executive
Karen McTavish, who joined
Watson this year following its
acquisition of Ascent
Pharmaceuticals.
Watson said the multi-year
rebranding campaign would cover
its facilities, operations and
commercial presence in more than
60 countries across the world, with
the firm to also transition to trading
under a new NYSE symbol in 2013.The above article was sent to subscribers in Pharmacy Daily's issue from 01 Nov 12 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 Nov 12
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.